Co-using drugs-what do we need to know?
- PMID: 33559244
- DOI: 10.1111/add.15419
Co-using drugs-what do we need to know?
Keywords: Cannabis; changes; co-use; drug harms; drug markets; tobacco; vaping.
Comment in
-
Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward.Addiction. 2021 Jul;116(7):1636-1637. doi: 10.1111/add.15497. Epub 2021 Apr 14. Addiction. 2021. PMID: 33855758 Free PMC article.
Comment on
-
Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it.Addiction. 2021 Jul;116(7):1622-1630. doi: 10.1111/add.15290. Epub 2020 Nov 20. Addiction. 2021. PMID: 33047862 Free PMC article.
References
-
- Meacham M. C., Roesch S. C., Strathdee S. A., Lindsay S., Gonzalez-Zuniga P., Gaines T. L. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico: latent classes of polydrug-polyroute use. Drug Alcohol Rev 2018; 37: 128-136.
-
- Hindocha C., McClure E. Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it. Addiction 2021; 116: 1622-1630.
-
- Helander A., Backberg M. Epidemiology of NPS based confirmed overdose cases: The STRIDA project. In: Maurer H., Brandt S., editors. New Psychoactive Substances Handbook of Experimental Pharmacology, Vol. 252. Berlin, Heidelberg: Springer; 2018, pp. 461-473.
-
- Miliano C., Margiani G., Fattore L., De Luca M. A. Sales and advertising channels of new psychoactive substances (NPS): internet, social networks, and smartphone apps. Brain Sci 2018; 8: 123.
-
- Pergolizzi J. V., LeQuang J. A., Taylor R., Raffa R. B. The “Darknet”: the new street for street drugs. J Clin Pharm Ther 2017; 42: 790-792.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
